BA.1, also known as S surface glycoprotein, is an immune escape variant. BA.1 is crucial for cell entry, pathogenicity, and is the key target of the adaptive immune response. BA.1 mediates attachment of the virus particle and entry into the host cell, and binds to the cellular protein angiotensin-converting enzyme 2 Subsequently, the BA.1 is primed by host cell proteases and drives the fusion of the viral and cellular membranes, which can take place at the plasma membrane or within endo-/lysosomes. BA.1 is an important target for vaccine development, antibody therapies and diagnostic antigen-based tests.